News Archive

Applications for the second cohort of the Together, Equitable, Accessible, Meaningful (TEAM) Training are now open!

WASHINGTON (Oct. 31, 2018) - Due to their broad antitumor activity that inhibits the function of microtubules, taxanes are common chemotherapeutic agents utilized for the management of multiple cancer types from breast to prostate.

Associate Professor at the Milken Institute School of Public Health at GW and GW Cancer Center member Kim Robien, PhD, RD, CSO, FAND, received the Distinguished Practice Award from the Oncology Nutrition practice group of the Academy of Nutrition and Dietetics on October 21st at the annual Food…

A host of representatives from throughout the George Washington University (GW) health care community joined GW Cancer Center leadership on Oct.

More people in the United States die from lung cancer than any other type of cancer (Centers for Disease Control and Prevention (CDC), 2018).

To commemorate Breast Cancer Awareness Month and celebrate the GW Cancer Center and GW Medical Faculty Associates’ Mammovan, the 7th Annual Blush Lunch was held at the Ritz-Carlton, West End in Washington, D.C. on October 17, 2018.

Dr. Brem is an expert in the field of radiology and breast cancer diagnosis and treatment. Since arriving at GW in 2000, Dr. Brem has been instrumental in developing a state-of-the-art, patient-focused breast imaging program that integrates compassionate care with the latest technology.

Adam Friedman, MD, is the senior author of a study on the efficacy of nanoparticles in therapies for triple-negative breast cancer.

Did you know that breast cancer in the United States is the most common cancer in women, except for skin cancers (CDC, 2018)?

WASHINGTON (Sept. 26, 2018) - Rong Li, PhD, will serve as chair of the Department of Biochemistry and Molecular Medicine at the George Washington University (GW) School of Medicine and Health Sciences.